Short answer · Medically reviewed summary · Last updated: 2026-05-08
The ICD-10 code for malignant neoplasm of the bronchus and lung is primarily categorized under C34, while the corresponding ICD-9 code is 162. These classification systems are essential for medical record-keeping, insurance billing, and tracking the clinical progression of lung cancer on a global scale. What are the specific ICD-10 and ICD-9 codes for lung cancer? In the ICD-10 system, lung cancer is classified under the C34 category, which is further subdivided based on the anatomical site of the tumor (e.g., C34.1 for the upper lobe, C34.2 for the middle lobe).
ICD10 code of Lung cancer and ICD9 code
ICD-10 and ICD-9 codes for Lung cancer, with classification details for clinicians, coders and patients.
The ICD-10 code for malignant neoplasm of the bronchus and lung is primarily categorized under C34, while the corresponding ICD-9 code is 162. These classification systems are essential for medical record-keeping, insurance billing, and tracking the clinical progression of lung cancer on a global scale.
What are the specific ICD-10 and ICD-9 codes for lung cancer?
In the ICD-10 system, lung cancer is classified under the C34 category, which is further subdivided based on the anatomical site of the tumor (e.g., C34.1 for the upper lobe, C34.2 for the middle lobe). The legacy ICD-9 system utilized code 162 to represent malignant neoplasms of the trachea, bronchus, and lung. Understanding these codes is vital for patients navigating the healthcare system, as they ensure accurate documentation of lung cancer diagnoses in electronic health records.
Why are these medical codes important for patients?
Accurate coding is not just for administrative purposes; it is critical for ensuring that insurance providers cover specialized treatments, such as targeted therapies or immunotherapies, which are often indicated for specific genetic mutations in lung cancer. At DiseaseMaps.org, where 53 members have shared their experiences with lung cancer, we emphasize that knowing your specific sub-type and associated diagnostic codes can help in accessing precision medicine and clinical trial opportunities.
How is lung cancer classified for clinical purposes?
Beyond broad ICD codes, lung cancer is clinically categorized into two primary types based on cell appearance under a microscope:
- Non-Small Cell Lung Cancer (NSCLC): Accounts for approximately 85% of all cases; includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
- Small Cell Lung Cancer (SCLC): Accounts for approximately 15% of cases; known for more rapid growth and spread compared to NSCLC.
Next steps
- Review your pathology report with your oncologist to confirm your specific histological subtype.
- Verify that your lung cancer diagnosis is correctly coded in your medical portal to prevent billing discrepancies.
- Connect with the 53 members of the lung cancer community at DiseaseMaps.org to share experiences and coping strategies.
- Consult a pulmonologist or thoracic oncologist to discuss the most recent clinical guidelines for your specific diagnosis.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- World Health Organization (WHO) - International Classification of Diseases (ICD-10 Browser).
- National Cancer Institute (NCI) - PDQ Cancer Information Summaries for Lung Cancer.
- American Cancer Society - Detailed Guide on Lung Cancer Classification.
- NIH Genetic and Rare Diseases Information Center (GARD).
